Have a feature idea you'd love to see implemented?
Let us know!
XTNT Xtant Medical Holdings Inc
Price (delayed)
$0.6002
Market cap
$78.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$107.72M
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal
Highlights
The company's gross profit has surged by 74% YoY and by 10% QoQ
The revenue has soared by 63% year-on-year and by 10% since the previous quarter
XTNT's net income has dropped by 101% since the previous quarter but it has soared by 62% year-on-year
The company's EPS has shrunk by 100% QoQ but it has surged by 78% YoY
XTNT's debt is up by 49% year-on-year and by 22% since the previous quarter
Key stats
What are the main financial stats of XTNT
Market
Valuations
Earnings
Shares outstanding
130.31M
Market cap
$78.21M
Enterprise value
$107.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.74
Price to sales (P/S)
0.7
EV/EBIT
N/A
EV/EBITDA
45.72
EV/Sales
0.97
Revenue
$110.94M
EBIT
-$1.55M
EBITDA
$2.36M
Free cash flow
-$17.21M
Per share
Balance sheet
Liquidity
EPS
-$0.02
Free cash flow per share
-$0.13
Book value per share
$0.35
Revenue per share
$0.85
TBVPS
$0.61
Total assets
$95.58M
Total liabilities
$50.57M
Debt
$34.99M
Equity
$45.01M
Working capital
$40.66M
Debt to equity
0.78
Current ratio
2.44
Quick ratio
0.94
Net debt/EBITDA
12.53
Margins
Efficiency
Dividend
EBITDA margin
2.1%
Gross margin
61.6%
Net margin
-3%
Operating margin
-12.3%
Return on assets
-3.6%
Return on equity
-6.7%
Return on invested capital
-2.1%
Return on capital employed
-2.3%
Return on sales
-1.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XTNT stock price
How has the Xtant Medical Holdings stock price performed over time
Intraday
-7.09%
1 week
-6.95%
1 month
1.59%
1 year
-48.7%
YTD
-46.88%
QTD
-11.21%
Financial performance
How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$110.94M
Gross profit
$68.36M
Operating income
-$13.61M
Net income
-$3.33M
Gross margin
61.6%
Net margin
-3%
XTNT's operating income has dropped by 106% year-on-year and by 13% since the previous quarter
XTNT's net income has dropped by 101% since the previous quarter but it has soared by 62% year-on-year
XTNT's net margin has dropped by 88% since the previous quarter but it has surged by 77% year-on-year
The company's gross profit has surged by 74% YoY and by 10% QoQ
Growth
What is Xtant Medical Holdings's growth rate over time
Valuation
What is Xtant Medical Holdings stock price valuation
P/E
N/A
P/B
1.74
P/S
0.7
EV/EBIT
N/A
EV/EBITDA
45.72
EV/Sales
0.97
The company's EPS has shrunk by 100% QoQ but it has surged by 78% YoY
The equity has grown by 45% YoY but it has contracted by 6% from the previous quarter
XTNT's P/B is 28% below its last 4 quarters average of 2.6
The revenue has soared by 63% year-on-year and by 10% since the previous quarter
The stock's price to sales (P/S) is 46% less than its last 4 quarters average of 1.4 and 37% less than its 5-year quarterly average of 1.2
Efficiency
How efficient is Xtant Medical Holdings business performance
Xtant Medical Holdings's ROA has plunged by 89% from the previous quarter but it has soared by 75% YoY
Xtant Medical Holdings's ROIC has soared by 86% YoY
The ROE has plunged by 86% from the previous quarter but it has soared by 75% YoY
The company's return on sales has surged by 85% YoY
Dividends
What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XTNT.
Financial health
How did Xtant Medical Holdings financials performed over time
The total assets is 89% more than the total liabilities
Xtant Medical Holdings's total liabilities has increased by 48% YoY and by 9% from the previous quarter
The total assets has grown by 47% YoY
XTNT's debt is 22% smaller than its equity
XTNT's debt is up by 49% year-on-year and by 22% since the previous quarter
The equity has grown by 45% YoY but it has contracted by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.